As a highly heterogeneous disease, breast cancer is classified into distinct molecular subtypes, among which estrogen receptor-positive (ER+) and estrogen receptor-negative (ER−) breast cancers represent two major clinical categories [2]. This evidence concerns the gene ESR1 and breast cancer.